2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Blood Loss, Surgical | D016063 | 6 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Nguyen TH et al. | Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media. | 2010 | J. Pharm. Pharmacol. | pmid:20636872 |
| Nguyen TH et al. | Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation. | 2010 | J. Pharm. Pharmacol. | pmid:20636873 |
| Gan L et al. | Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. | 2010 | Int J Pharm | pmid:20558263 |
| Cohen-Avrahami M et al. | H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac. | 2010 | Colloids Surf B Biointerfaces | pmid:20189781 |
| Bitan-Cherbakovsky L et al. | Solubilization of vitamin E into H(II) LLC mesophase in the presence and in the absence of vitamin C. | 2010 | Langmuir | pmid:20175578 |
| Yaghmur A et al. | Effects of pressure and temperature on the self-assembled fully hydrated nanostructures of monoolein-oil systems. | 2010 | Langmuir | pmid:19681634 |
| Issa JP et al. | Collagen fibers evaluation after rhBMP-2 insertion in critical-sized defects. | 2009 Jul-Aug | Micron | pmid:19394235 |
| Long JZ et al. | Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. | 2009 | Nat. Chem. Biol. | pmid:19029917 |
| Libster D et al. | Molecular interactions in reverse hexagonal mesophase in the presence of Cyclosporin A. | 2009 | Int J Pharm | pmid:18977286 |
| Pichot R et al. | Mixed-emulsifier stabilised emulsions: Investigation of the effect of monoolein and hydrophilic silica particle mixtures on the stability against coalescence. | 2009 | J Colloid Interface Sci | pmid:18977494 |
| Uyama M et al. | Useful modified cellulose polymers as new emulsifiers of cubosomes. | 2009 | Langmuir | pmid:19296640 |
| Fong WK et al. | Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo. | 2009 | J Control Release | pmid:19331865 |
| Rizwan SB et al. | Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics. | 2009 | J Pharm Sci | pmid:19340889 |
| Vandoolaeghe P et al. | Neutron reflectivity studies of the interaction of cubic-phase nanoparticles with phospholipid bilayers of different coverage. | 2009 | Langmuir | pmid:19714826 |
| Vandoolaeghe P et al. | Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction. | 2009 | Langmuir | pmid:19714888 |
| Issa JP et al. | Effect of recombinant human bone morphogenetic protein-2 on bone formation in the acute distraction osteogenesis of rat mandibles. | 2009 | Clin Oral Implants Res | pmid:19719732 |
| Fatouros DG et al. | Colloidal structures in media simulating intestinal fed state conditions with and without lipolysis products. | 2009 | Pharm. Res. | pmid:19003522 |
| Simonetti LD et al. | Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway. | 2009 | Eur J Pharm Biopharm | pmid:19442727 |
| Murgia S et al. | Orientation and specific interactions of nucleotides and nucleolipids inside monoolein-based liquid crystals. | 2009 | J Phys Chem B | pmid:19569723 |
| Lai J et al. | Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin. | 2009 | AAPS PharmSciTech | pmid:19636709 |